Cancer Pain Single Nucleotide Polymorphisms (SNPs)

Erasmus University

Status: Completed

Conditions: Cancer; Pain

Study type: Observational

Funder types: Other

Identifiers

NCT00956878

MEC2008-166

Details and patient eligibility

About

Cancer pain is common in advanced cancer patients. Opioids are the mainstay of treatment in cancer pain. Responsiveness to and tolerability of opioids is, amongst others, determined by small variations in human DNA. Using blood samples from clinically well-defined cancer pain patients, the investigators are going to analyze single nucleotide polymorphisms (SNPs) in genes that are known to be involved in responsiveness to opioids and sensitivity to pain.

Enrollment: 243 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cancer pain patients

Exclusion criteria

• Patients not able to provide informed consent

Trial design

243 participants in 1 patient group

Cancer Pain Patients